SMS Pharmaceuticals Limited (SMS Pharma), a Hyderabad based diversified and fully integrated pharmaceutical company, with interests in Active Pharmaceutical Ingredients (API) and Intermediates announced its financial results for the quarter ended 30th September, 2023.
SMS Pharmaceuticals Limited, a Hyderabad based diversified and fully integrated pharmaceutical company, with interests in active pharmaceutical ingredients (API) and intermediates posted 153% rise in net profit at Rs. 23.6 crore for the first quarter ended 30th June 2021.
British drugmaker GlaxoSmithKlineNSE -0.23 % on Wednesday said it is recalling heartburn drug Ranitidine from India, a day after the country’s drug regulator asked pharma companies to check their products for carcinogen
SMS Pharmaceuticals has received approval from the US health regulator for its Andhra Pradesh based manufacturing facility.nnThe company has received approval from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh, SMS Pharmaceuticals said in a regulatory filing.
SMS Pharmaceuticals has rallied 11% to Rs 114, extending its previous day’s 5% gain on the BSE, after the company sub-divided the face value of equity shares of the company from Rs 10 to Rs 1. The stock turned ex-stock split on Thursday, December 17, 2015.